Table: Jcr Pharmaceuticals -Q1 group results

JCR Pharmaceuticals

29/07/2021 08:00

Jul 29 (Reuters)- 
             Jcr Pharmaceuticals Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended       Year to 
                  Jun 30, 2021        Jun 30, 2020     Mar 31, 2022 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               9.81                5.18             49.00    
                   (+89.4 pct)         (+0.5 pct)       (+62.9 pct) 
  Operating           2.98               784 mln           18.70    
                  (+280.3 pct)         (+70.2 pct)     (+126.1 pct) 
  Recurring           3.00               862 mln           18.70    
                  (+247.6 pct)         (+84.8 pct)     (+120.3 pct) 
  Net                 1.53               767 mln           13.30    
                   (+99.8 pct)        (+107.4 pct)      (+92.9 pct) 
  EPS               12.40 yen           6.22 yen        107.68 yen  
  EPS Diluted       12.34 yen           6.19 yen                    
  Ann Div                                                16.00 yen  
  -Q2 div                               18.00 yen        8.00 yen   
  -Q4 div                               7.50 yen         8.00 yen   
  
  NOTE - Jcr Pharmaceuticals Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4552.T